Literature DB >> 17723923

Drug-induced liver injury associated with HIV medications.

Mamta K Jain1.   

Abstract

Antiretroviral therapy (ART) for HIV infection frequently has been associated with elevated liver enzyme levels. Determining the cause of elevated liver enzyme levels in patients who have HIV is difficult because ART usually consists of three different drugs, patients may be taking additional hepatotoxic medications and patients who have HIV often suffer from other liver diseases. Several agents, however, are recognized as having noteworthy and specific patterns of toxicity. This article reviews the different HIV drug classes, incidence of elevated liver enzyme values by class and by individual drug, risk factors, specific toxicities, and possible mechanisms of injury.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17723923     DOI: 10.1016/j.cld.2007.06.008

Source DB:  PubMed          Journal:  Clin Liver Dis        ISSN: 1089-3261            Impact factor:   6.126


  6 in total

1.  Correlation between HIV viral load and aminotransferases as liver damage markers in HIV infected naive patients: a concordance cross-sectional study.

Authors:  José Antonio Mata-Marín; Jesús Gaytán-Martínez; Bernardo Horacio Grados-Chavarría; José Luis Fuentes-Allen; Carla Ileana Arroyo-Anduiza; Alfredo Alfaro-Mejía
Journal:  Virol J       Date:  2009-10-30       Impact factor: 4.099

2.  Nevirapine-induced liver lipid-SER inclusions and other ultrastructural aberrations.

Authors:  Jayram Sastry; Heba Mohammed; Maria Mercedes Campos; Jack Uetrecht; Mones Abu-Asab
Journal:  Ultrastruct Pathol       Date:  2018-02-09       Impact factor: 1.094

Review 3.  An Update on Drug-induced Liver Injury.

Authors:  Harshad Devarbhavi
Journal:  J Clin Exp Hepatol       Date:  2012-09-21

4.  Metabolomics in Placental Tissue from Women Living with HIV.

Authors:  Huda B Al-Kouatly; Rachel K Scott; Mona M Makhamreh; Gary Cunningham; Timothy Visclosky; Brian O Ingram; Kengo Inagaki; Natella Rakhmanina; Brian Kirmse
Journal:  AIDS Res Hum Retroviruses       Date:  2021-12-13       Impact factor: 2.205

Review 5.  Hepatotoxicity of Contemporary Antiretroviral Drugs: A Review and Evaluation of Published Clinical Data.

Authors:  Ashley O Otto; Christina G Rivera; John D Zeuli; Zelalem Temesgen
Journal:  Cells       Date:  2021-05-20       Impact factor: 6.600

6.  Viral hepatitis and HIV-associated tuberculosis: risk factors and TB treatment outcomes in Thailand.

Authors:  Chawin Sirinak; Wanitchaya Kittikraisak; Duangporn Pinjeesekikul; Pricha Charusuntonsri; Phinai Luanloed; La-ong Srisuwanvilai; Sriprapa Nateniyom; Somsak Akksilp; Sirirat Likanonsakul; Wanchai Sattayawuthipong; Channawong Burapat; Jay K Varma
Journal:  BMC Public Health       Date:  2008-07-18       Impact factor: 3.295

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.